• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清学应对 SARS-CoV-2 的变异性:通过测定亲和力(功能亲合力)解决模糊性的可能性。

The variability of the serological response to SARS-corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).

机构信息

Institute of Virology, Medical Center, University of Freiburg, Freiburg, Germany.

Faculty of Medicine, University of Freiburg, Freiburg, Germany.

出版信息

J Med Virol. 2021 Jan;93(1):311-322. doi: 10.1002/jmv.26262. Epub 2020 Jul 15.

DOI:10.1002/jmv.26262
PMID:32633840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361859/
Abstract

Data on the serological response toward severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 16 recent reports were analyzed and a high degree of variability was shown. Immunoglobulin M (IgM) responses were either found earlier than IgG, or together with IgG, later than IgG, or were missing. Therefore, clear distinctions between early, intermediate, and past infections are obviously not possible merely on the basis of IgM and IgG determinations. A review of publications on the serology of other virus groups shows that variable IgM responses can be found as well and therefore are not unique for SARS-CoV-2 infections. A model to explain this variability is proposed. The inclusion of avidity determination into regular diagnostic procedures has allowed to resolve such "atypical" serological constellations. The potential use of avidity determination for the diagnosis of COVID-19, for risk assessment, epidemiological studies, analysis of cross reactions, as well as for the control of vaccination programs is suggested and discussed.

摘要

对 16 份近期报告中关于严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)血清学反应的数据进行了分析,结果显示存在高度的可变性。免疫球蛋白 M(IgM)的反应要么早于 IgG,要么与 IgG 一起,晚于 IgG,要么缺失。因此,仅基于 IgM 和 IgG 的测定,显然不可能清楚地区分早期、中期和过去的感染。对其他病毒群血清学的文献综述表明,也可以发现可变的 IgM 反应,因此这并不是 SARS-CoV-2 感染所特有的。提出了一个解释这种可变性的模型。将亲和力测定纳入常规诊断程序中,使得能够解决这种“非典型”的血清学模式。建议并讨论了将亲和力测定用于 COVID-19 的诊断、风险评估、流行病学研究、交叉反应分析以及疫苗接种计划的控制的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/8e678f63f6ac/JMV-93-311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/b7ea9d6ebe29/JMV-93-311-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/c0dc525ad898/JMV-93-311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/05d037f4fd11/JMV-93-311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/8e678f63f6ac/JMV-93-311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/b7ea9d6ebe29/JMV-93-311-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/c0dc525ad898/JMV-93-311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/05d037f4fd11/JMV-93-311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc9d/7361859/8e678f63f6ac/JMV-93-311-g003.jpg

相似文献

1
The variability of the serological response to SARS-corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).血清学应对 SARS-CoV-2 的变异性:通过测定亲和力(功能亲合力)解决模糊性的可能性。
J Med Virol. 2021 Jan;93(1):311-322. doi: 10.1002/jmv.26262. Epub 2020 Jul 15.
2
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.用 SARS-CoV-2 IgG-IgM 抗体快速检测试剂盒检测来自欧洲和非洲的大流行前血标本时,出现了出乎意料的高频率非特异性反应,这表明 IgM 是“阿喀琉斯之踵”。
J Med Virol. 2021 Apr;93(4):2196-2203. doi: 10.1002/jmv.26628. Epub 2020 Nov 22.
3
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.四种 SARS-CoV-2 抗体检测试剂在 COVID-19 患者及细菌性和非 SARS-CoV-2 病毒呼吸道感染患者中的诊断性能比较。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1983-1997. doi: 10.1007/s10096-021-04285-4. Epub 2021 Jun 9.
4
Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.弥补 COVID-19 诊断检测中的血清学差距:抗 SARS-CoV-2 IgA 抗体的价值。
J Med Virol. 2021 Mar;93(3):1436-1442. doi: 10.1002/jmv.26422. Epub 2020 Aug 21.
5
Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.采用侧向流动免疫层析 IgG/IgM 抗体检测法对 SARS-CoV-2 特异性抗体亲和力进行定性评估。
J Med Virol. 2021 Feb;93(2):1141-1144. doi: 10.1002/jmv.26344. Epub 2020 Aug 2.
6
The challenge of avidity determination in SARS-CoV-2 serology.在 SARS-CoV-2 血清学中确定亲和力的挑战。
J Med Virol. 2021 May;93(5):3092-3104. doi: 10.1002/jmv.26863. Epub 2021 Feb 19.
7
Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.五种用于 SARS-CoV-2 抗体诊断的免疫分析方法在真实临床常规检测环境中的临床诊断性能评估。
Pan Afr Med J. 2021 May 3;39:3. doi: 10.11604/pamj.2021.39.3.26471. eCollection 2021.
8
Incomplete IgG avidity maturation after seasonal coronavirus infections.季节性冠状病毒感染后 IgG 亲和力成熟不完全。
J Med Virol. 2022 Jan;94(1):186-196. doi: 10.1002/jmv.27291. Epub 2021 Aug 27.
9
Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.血清学检测抗 SARS-CoV-2 抗体可提高 COVID-19 患者诊断的灵敏度。
Med Microbiol Immunol. 2021 Dec;210(5-6):283-289. doi: 10.1007/s00430-021-00721-6. Epub 2021 Sep 25.
10
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.新型冠状病毒血清学检测方法在 SARS-CoV-2 感染和 COVID-19 诊断中的研究进展。
Front Public Health. 2021 Feb 18;8:620222. doi: 10.3389/fpubh.2020.620222. eCollection 2020.

引用本文的文献

1
Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach.新冠疫苗有效性和免疫原性面临的挑战:一项采用系统方法的叙述性综述
Vaccines (Basel). 2025 Jul 24;13(8):789. doi: 10.3390/vaccines13080789.
2
A Prospective Study of Immune Response After COVID-19 or Vaccination and Correlation Between Avidity Index and Neutralizing Capacity.新型冠状病毒肺炎感染或疫苗接种后免疫反应的前瞻性研究以及亲和力指数与中和能力之间的相关性
Adv Virol. 2025 Jun 16;2025:2265813. doi: 10.1155/av/2265813. eCollection 2025.
3
Use of a Multiplex Immunoassay Platform to Investigate Multifaceted Antibody Responses in SARS-CoV-2 Vaccinees with and Without Prior Infection.

本文引用的文献

1
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.体液免疫反应在感染 SARS-CoV-2 后的动态变化和再次感染的可能性。
J Gen Virol. 2020 Aug;101(8):791-797. doi: 10.1099/jgv.0.001439.
2
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients.238 例住院患者血清严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)抗体检测的初步研究。
Microbes Infect. 2020 May-Jun;22(4-5):206-211. doi: 10.1016/j.micinf.2020.05.008. Epub 2020 May 18.
3
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.
使用多重免疫分析平台研究有或无既往感染的新冠病毒疫苗接种者的多方面抗体反应。
COVID. 2025 Apr;5(4). doi: 10.3390/covid5040044. Epub 2025 Mar 22.
4
Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal.塞内加尔达喀尔女性性工作者中疫情前针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的交叉反应性抗体及细胞免疫反应
Front Public Health. 2025 Jan 23;13:1522733. doi: 10.3389/fpubh.2025.1522733. eCollection 2025.
5
Avidity maturation of anti-spike IgG after vaccination in COVID-19 convalescent vs COVID-19 naïve patients.新冠康复患者与未感染新冠患者接种疫苗后抗刺突蛋白IgG的亲和力成熟情况。
APMIS. 2025 Jan;133(1):e13489. doi: 10.1111/apm.13489. Epub 2024 Nov 7.
6
Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry.用同位素稀释质谱法定量 SARS-CoV-2 单克隆 IgG 质量分数。
Anal Bioanal Chem. 2024 Apr;416(10):2423-2437. doi: 10.1007/s00216-024-05205-z. Epub 2024 Mar 1.
7
Risk of SARS-CoV-2 transmission in the close contacts in a small rural area in the Veneto Region (NE-Italy): past evidence for future scenarios.新冠病毒在威尼托地区(意大利东北部)一个小村庄密切接触者中的传播风险:过去的证据对未来的情况。
Front Public Health. 2023 Sep 5;11:1223109. doi: 10.3389/fpubh.2023.1223109. eCollection 2023.
8
Brief update on coronavirus disease 2019 (COVID-19) diagnostics.2019冠状病毒病(COVID-19)诊断的简要更新。
Adv Lab Med. 2020 Nov 12;1(4):20200099. doi: 10.1515/almed-2020-0099. eCollection 2020 Dec.
9
The quantity and quality of anti-SARS-CoV-2 antibodies show contrariwise association with COVID-19 severity: lessons learned from IgG avidity.抗 SARS-CoV-2 抗体的数量和质量与 COVID-19 严重程度呈相反关联:从 IgG 亲和力中得到的教训。
Med Microbiol Immunol. 2023 Jun;212(3):203-220. doi: 10.1007/s00430-023-00763-y. Epub 2023 Apr 27.
10
Multiplexed evaluation of immunity against SARS-CoV-2 variants using surface enhanced fluorescence from a nanostructured plasmonic chip.利用纳米结构等离子体芯片的表面增强荧光对 SARS-CoV-2 变体的免疫进行多重评估。
J Nanobiotechnology. 2022 Dec 15;20(1):533. doi: 10.1186/s12951-022-01687-0.
SARS-CoV-2 疫情意大年夜利中间爆发严重川崎病样病:一项不雅察性队列研究。
Lancet. 2020 Jun 6;395(10239):1771-1778. doi: 10.1016/S0140-6736(20)31103-X. Epub 2020 May 13.
4
Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2.新冠病毒 IgM 和 IgG 快速检测的评估;一种评估既往是否感染过严重急性呼吸综合征冠状病毒 2 的有效工具。
Infect Ecol Epidemiol. 2020 Apr 14;10(1):1754538. doi: 10.1080/20008686.2020.1754538. eCollection 2020.
5
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫球蛋白G和IgM抗体概况
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.
6
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.新型冠状病毒肺炎患者的抗体检测及动态特征。
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934. doi: 10.1093/cid/ciaa461.
7
Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays.使用全自动 MAGLUMI 2019 - nCoV IgG 和 IgM 化学发光免疫分析法评估对 SARS-CoV-2 的免疫反应。
Clin Chem Lab Med. 2020 Jun 25;58(7):1156-1159. doi: 10.1515/cclm-2020-0473.
8
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics.用于 SARS-CoV-2 IgM/IgG 的化学发光免疫分析的分析性能和抗体动力学。
Clin Chem Lab Med. 2020 Jun 25;58(7):1081-1088. doi: 10.1515/cclm-2020-0443.
9
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.血清免疫层析法在 SARS-CoV-2 感染的 COVID-19 患者诊断中的应用。
J Infect. 2020 Jul;81(1):e28-e32. doi: 10.1016/j.jinf.2020.03.051. Epub 2020 Apr 10.
10
Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.血清抗体在 2019 冠状病毒病中的诊断价值及动态变化。
Int J Infect Dis. 2020 May;94:49-52. doi: 10.1016/j.ijid.2020.03.065. Epub 2020 Apr 3.